Effects of CoQ10, melatonin, vitamin B groups, vitamin D. and probiotic on reducing COVID-19 symptoms during recovery

Phase 3

Recruiting

Conditions: COVID-19.
COVID-19, virus identified
U07.1

Registration Number: IRCT20140804018677N21

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 80

Inclusion Criteria

Diagnosed with COVID-19 according to WHO criteria
Willing to participate in the study
Age 18 years and older

Exclusion Criteria

Discharged with positive PCR test for COVID-19
Pregnancy
Lactation
Vitamin D deficiency based on lab test (<30 ng/ml)
Enteral or parental nutrition requirement after discharge

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatigue Severity. Timepoint: Baseline and at the end of the study. Method of measurement: Fatigue Severity Scale (FSS).;Sleep Quality. Timepoint: Baseline and at the end of the study. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).;Anxiety. Timepoint: Baseline and at the end of the study. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Constipation. Timepoint: Baseline and at the end of the study. Method of measurement: Patient Assessment of Constipation-Symptoms (PAC-SYM).;Headache severity. Timepoint: Baseline and at the end of the study. Method of measurement: Visual analog scale-VAS.;Headache duration. Timepoint: Baseline and at the end of the study. Method of measurement: Headache diary.;Headache Frequency. Timepoint: Baseline and at the end of the study. Method of measurement: Headache diary.

Secondary Outcome Measures